Tuesday, February 21, 2023
Image
![NIH Default Logo](/sites/default/files/styles/half_width_small/public/2020-10/news-default.png?itok=rPIuiSJC)
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide regulatory affairs support and related services for the Blueprint MedTech (BPMT) program, a new multi-institute/center initiative at the National Institutes of Health (NIH) supporting development of translational neurological devices.